Aehr Test Systems

AEHR remains in a Stage 4 decline with confirmed lower-high / lower-low structure. Recent rebound failed at intermediate moving averages, reinforcing the bearish medium-term bias. With mean reversion ineligible and clear rejection at the 20- and 50-day DMAs, execution now favors selling on resistance failure.

• ↑Q4 FY’26 revenue set to rise 32.6% YoY to $18.7M
• ↑Multiple follow-on FOX-XP orders highlight strong AI data center demand
• ↓Profitability challenges persist with EPS at -$0.01 and low margins